KOOL - ThermoGenesis Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

ThermoGenesis Holdings, Inc.

2711 Citrus Road
Rancho Cordova, CA 95742
United States
916-858-5100
http://www.cescatherapeutics.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees53

Key Executives

NameTitlePayExercisedYear Born
Dr. Xiaochun Xu M.B.A., Ph.D.Chairman, CEO & Pres460kN/A1971
Mr. Jeff CaublePrincipal Financial & Accounting Officer160kN/A1973
Mr. James Xu J.D., L.L.M., M.B.A.Director, Gen. Counsel, Sr. VP of Legal Affairs & Cybersecurity and Corp. Sec.60kN/A1971
Mr. Philip H. CoelhoChief Technology OfficerN/AN/A1944
Ms. Haihong ZhuPres of ThermoGenesisN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies for cell-based therapies in the United States, China, rest of Asia, Europe, and internationally. The company operates through two segments, Clinical Development and Device. It offers AutoXpress System, an automated system for the isolation, collection and storage of hematopoietic stem cell concentrates derived from cord blood and peripheral blood; Point-of CareXpress System for the rapid, automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells; CAR-TXpress System that addresses the critical unmet need for chemistry, manufacturing and controls improvement of the emerging CAR-T therapies for cancer patients; BioArchive Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for stem cell samples and clinical products; and manual disposables. The company is also developing autologous stem cell-based therapeutics that address medical needs for applications in the vascular, cardiology, and orthopedic markets. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.

Corporate Governance

ThermoGenesis Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.